References

References for "Good practice recommendations for antifungal stewardship in haemato-oncology"

Ananda-Rajah MR, Slavin MA, Thursky KT. The case for antifungal stewardship. Curr Opin Infect Dis.2012; 25: 107-15

Gutierrez F, Wall PG, Cohen J. An audit of the use of antifungal agents. J Antimicrob Chemother. 1996; 37: 175-85

Micallef C, Ashiru-Oredope D, Hansraj S, et al. An investigation of antifungal stewardship programmes in England. Med. Microbiol. 2017; 66: 1581-1589

Nivoix Y, Launoy A, Lutun P, et al. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother. 2012; 67: 2506-13

Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17: 383 – 39

Sutepvarnon A, Apisarnthanarak A, Camins B, et al. Inappropriate use of antifungal medications in a tertiary care center in thailand: A prospective study. Infect control Hosp Epidemiol. 2008; 29: 370-3

Valerio M, Rodriguez-Gonzalez CG, Munoz P, et al. Evaluation of antifungal use in a tertiary care institution: Antifungal stewardship urgently needed. . J Antimicrob Chemother. 2014; 69: 1993-9

Worldwide emergence of resistance to antifungal drugs challenges human health and food security; Mathew C Fisher et al. 2018

Content updated January 2024